Why the study?
Does chest computed tomography (CT) scoring predict the severity of amiodarone-induced pulmonary toxicity in patients receiving long-term amiodarone therapy?
Population
34 patients who underwent amiodarone treatment for more than 2 years with a cumulative dose > 100 g, most…
Comparison
Chest computed tomography scoring vs Patients without an increased APT CT score
Design
Cohort
Key result
Patients with positive amiodarone-induced pulmonary toxicity CT scores exhibited significantly lower diffusion capacity for carbon monoxide compared to those with negative scores (70.2% vs. 89.7%, p=0.011).
Authors
Loading...
Supports CT scoring for amiodarone pulmonary toxicity severity assessment; hypothesis-generating and requires prospective validation.
Cohort (n=34)
No
Does chest computed tomography (CT) scoring predict the severity of amiodarone-induced pulmonary toxicity in patients receiving long-term amiodarone therapy?
Absolute Event Rate: 70.2% vs 89.7%
p-value: p=0.011
Chest CT scoring is a feasible and useful diagnostic index for assessing the severity of amiodarone-induced pulmonary toxicity in patients on long-term therapy.
Kang et al. (2014) conducted a cohort in Amiodarone-induced pulmonary toxicity (n=34). Positive APT CT score vs. Negative APT CT score was evaluated on Diffusion capacity for carbon monoxide (DLCO) (p=0.011). Patients with positive amiodarone-induced pulmonary toxicity CT scores exhibited significantly lower diffusion capacity for carbon monoxide compared to those with negative scores (70.2% vs. 89.7%, p=0.011).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: